Mizuho Securities USA’s Cartesian Growth Corp II RENE Stock Holding History

Mizuho Securities USA’s Portfolio RENE Stock Details RENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,231,705	Closed	-$14.6M	–	729
2025 Q2	$14.6M	Buy	1,231,705 +80,753	+7%	+$961K	0.31%	52
2025 Q1	$13.6M	Buy	1,150,952 +93,152	+9%	+$1.09M	0.29%	60
2024 Q4	$12.3M	Buy	1,057,800 +70,300	+7%	+$814K	0.22%	81
2024 Q3	$11.3M	Buy	987,500 +594,424	+151%	+$6.76M	0.24%	63
2024 Q2	$4.4M	Buy	393,076 +230,862	+142%	+$2.59M	0.1%	199
2024 Q1	$1.79M	Sell	162,214 -153,846	-49%	-$1.7M	0.04%	90
2023 Q4	$3.45M	Buy	+316,060	New	+$3.44M	0.08%	66

Other funds holding RENE

Crossingbridge Advisors Pleasantville, New York $567M AUM 0.34% 1-Year Est. Return

Mizuho Securities USA's RENE Position: Q3 2025 in Review

Mizuho Securities USA sold out of Cartesian Growth Corp II (RENE) in Q3 2025, closing a stake of 1,231,705 shares — an estimated $14.6M sold.

Mizuho Securities USA first reported a position in RENE in Q4 2023 and held it in 7 quarters. The position peaked at $14.6M in Q2 2025. 1 fund tracked by Wall St. Rank holds RENE as of Q3 2025.

Mizuho Securities USA reported no remaining Cartesian Growth Corp II position as of Q3 2025 after selling out during the quarter.
Mizuho Securities USA sold 1,231,705 Cartesian Growth Corp II shares in Q3 2025, an estimated $14.6M.
Mizuho Securities USA first reported a position in Cartesian Growth Corp II in Q4 2023 and held it in 7 quarters.
Mizuho Securities USA's Cartesian Growth Corp II position peaked at $14.6M in Q2 2025.
1 fund tracked by Wall St. Rank held Cartesian Growth Corp II as of Q3 2025.

Based on Mizuho Securities USA's 13F filing for Q3 2025, filed 22 Oct 2025.